RESPIRATORY SYNCYTIAL VIRUS INFECTIONS
Clinical trials for RESPIRATORY SYNCYTIAL VIRUS INFECTIONS explained in plain language.
Never miss a new study
Get alerted when new RESPIRATORY SYNCYTIAL VIRUS INFECTIONS trials appear
Sign up with your email to follow new studies for RESPIRATORY SYNCYTIAL VIRUS INFECTIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New nasal vaccine aims to protect little lungs from RSV
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a new nasal spray vaccine (BLB-201) to see if it is safe and helps the body fight RSV, a common virus that can cause serious breathing problems in babies and young children. About 137 infants and children aged 8 to 59 months, some who have had RSV before and some…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS INFECTIONS
Phase: PHASE1, PHASE2 • Sponsor: Blue Lake Biotechnology Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 30, 2026 15:49 UTC
-
Common antibiotic may shorten hospital stays for kids fighting severe RSV
Disease control Recruiting nowThis study tests whether the antibiotic azithromycin can help children with severe RSV infection who need breathing support in the ICU. Researchers will measure how long children stay in the hospital and need oxygen. The goal is to see if azithromycin speeds up recovery by reduci…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS INFECTIONS
Phase: PHASE3 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC